Roche has offered $89/sh in cash for the 44% of DNA’s shares it does not already own. Now Roche must negotiate a deal with DNA’s BoD and also obtain approval of the deal by a majority of DNA’s non-Roche shareholders.
The buyout price in the final deal will be:
a) $89-94 b) $95-104 c) $105-114 d) $115-124 e) $125 or more f) None—the deal will not go through
Market Data 
Markets 
AI
